Business
Premier Biomedical Announces the Addition of Dr. James Frincke to Scientific Advisory Board
Premier Biomedical Announces the Addition of Dr. James Frincke to Scientific Advisory Board.
About this update from Premier Biomedical Inc
[{"type":"text","content":"\n \n Premier \n Biomedical, Inc. (OTCQB: \"BIEI\") \n announced the addition of Dr. James Frincke to their Scientific Advisory \n Board effective immediately. Dr. Frincke will report to co-founder and \n Chairman of the Scientific Advisory Board, Dr. Mitchell S. Felder, MD, \n and to the President and CEO, William A. Hartman.\n \n \n James Frincke, PhD, is a Research & Development Consultant at Red Spot \n Biosciences, LLC, currently providing pro bono consultation to \n physicians globally to discover treatments for diseases, such as \n Crohn's, Rheumatoid Arthritis, Alzheimer's, Parkinson's and Type 1 \n Diabetes. With over 30 years of experience in the biotechnology \n industry, Dr. Frincke has successfully managed major development \n programs for all phases of pharmaceutical development. Dr. Frincke \n received his PhD and BS degrees in Organic Chemistry from the University \n of California, Davis and has performed postdoctoral work in the area of \n drug metabolism.\n \n \n Prior to Dr. Frincke’s work as a consultant, he was VP of R&D Operations \n at Harbor Therapeutics, San Diego, CA, where he focused on treatments \n for age-related diseases. He is a world renowned pharmaceutical \n scientist and has raised hundreds of millions of dollars to fund new and \n groundbreaking small molecule compound (monoclonal antibody), \n biological, and cellular and gene therapies. Dr. Frincke is a prolific \n inventor with 24 US and 120 International patents to his credit. He has \n also published 75 peer reviewed journal articles and has submitted 32 \n new drug applications to the FDA.\n \n \n Mitchell S. Felder, Co-Founder and Chairman of Premier Biomedical’s \n Scientific Advisory Board stated, \"Dr. Frincke brings an outstanding \n level of drug development experience and business expertise to Premier. \n Together with the other distinguished members of our Scientific Advisory \n Board, Dr. Frincke will help guide and expedite the advancement of our \n R&D programs currently underway at the University of Texas at El Paso \n (UTEP), and other research partners, to combat breast and other forms of \n cancer, and other gene therapy related treatments for Amyotrophic \n Lateral Sclerosis (ALS), Muscular Dystrophy (MD) and Alzheimer’s \n Disease.\"\n \n \n About Premier Biomedical, Inc.\n \n \n Premier Bi...